GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)

SolicitationNo Set AsideActive

Puntos Clave

  • Aproximadamente 1 semanas para preparar su respuesta
  • Reservado para empresas No Set Aside
  • Trabajo a realizarse en Washington, DC
  • Industria: Research and Development in Biotechnology (except Nanobiotechnology)

Detalles del Contrato

ID de Aviso
ARPA-H-SOL-25-129
Tipo de Oportunidad
Solicitation
Sub-Agencia
NATIONAL INSTITUTES OF HEALTH
Oficina
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Fecha de Publicación
Friday, October 10, 2025
Fecha Límite de Respuesta
Friday, February 27, 2026
Código PSC
AN13
Reserva
No Set Aside
Lugar de Desempeño
Washington, DC, 20005
Estado
Activo

Descripción

October 03, 2025: Special Notice (ARPA-H-SN-26-140) posted to SAM.GOV. GIVE ISO (ARPA-H-SOL-25-129) Amendment 01 posted. For details, please see the Summary of Changes (pg 2) in the attached (GIVE_ISO_Amend_01_ 20251003). __________________________________________________________ September 25, 2025: The Advanced Research Projects Agency for Health (ARPA-H) Genetic Medicines And Individualized Manufacturing For Everyone (GIVE) Program aims to accelerate biomanufacturing equipment and process innovation, digital transformation, next generation therapies, and commercial adoption all at once focused on accelerating innovation in the manufacture, testing, and release of RNA-containing modalities. GIVE seeks to harness human-machine collaboration, eliminate scale-up costs, and drive toward a fun

Por Qué Importa Esta Oportunidad

HEALTH AND HUMAN SERVICES, DEPARTMENT OF está buscando activamente contratistas calificados para research and development in biotechnology (except nanobiotechnology) con reserva para empresas No Set Aside en Washington, DC. Esta designación de reserva significa que las empresas elegibles enfrentan menos competencia de empresas más grandes.